1. Drip-and-ship toward mothership model for mechanical thrombectomy during COVID-19 pandemic: a retrospective analysis

   • Matteo Paolucci
   • Sara Biguzzi
   • Marco Longoni

   COVID-19 31 January 2022 Pages: 1 - 7

   

2. The future of neurology after the COVID-19 pandemic according to neurology residents

   • Tommaso Ercoli
   • Francesco Barbato
   • on behalf of SIgN

   COVID-19 13 October 2022 Pages: 9 - 12

   

3. Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis

   • Qian Zheng
   • Pengfei Ma
   • Zhanhui Feng

   COVID-19 15 October 2022 Pages: 13 - 17

   

4. Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

   • Madhumitha Katta
   • Blessy Aksa Mathew
   • Anjana Munshi

   Review Article 06 September 2022 Pages: 19 - 36

   

5. The use of dual antiplatelet therapy for ischemic cerebrovascular events

   • Francesco Mele
   • Claudia Gendarini
   • Leonardo Pantoni

   Review Article Open access 17 September 2022 Pages: 37 - 43

   

6. Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective

   • Giacomo Lus
   • Marco André Bassano
   • Luigi Maria Edoardo Grimaldi

   Review Article Open access 17 September 2022 Pages: 45 - 58

   

7. The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis

   • Nader Salari
   • Razie Hasheminezhad
   • Masoud Mohammadi

   Review Article 17 September 2022 Pages: 59 - 66

   

8. The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): a systematic review and meta-analysis—an update

   • Alireza Zali
   • Mahsa Motavaf
   • Omid Mirmosayyeb

   Review Article 05 September 2022 Pages: 67 - 82

   

9. Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?

   • Guadalupe Garis
   • Michael Haupts
   • Helmut Hildebrandt

   Review Article Open access 20 September 2022 Pages: 83 - 98

   

10. Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems

    • Mojgan Oshaghi
    • Masoumeh Kourosh-Arami
    • Maryam Roozbehkia

    Review Article 28 September 2022 Pages: 99 - 113

11. Clonazepam for the management of sleep disorders

    • Alberto Raggi
    • Maria Paola Mogavero
    • Raffaele Ferri

    Review Article 16 September 2022 Pages: 115 - 128

    

12. Persistent positional perceptual dizziness in clinical practice: a scoping review

    • Soumyajit Das
    • Chandra Sekhar Annam
    • Ramesh Seepana

    Review Article 22 August 2022 Pages: 129 - 135

    

13. Neurology of cancer immunotherapy

    • Amedeo De Grado
    • Federica Cencini
    • Alberto Priori

    Review Article Open access 16 September 2022 Pages: 137 - 148

    

14. Inflammation, metabolic dysregulation and environmental neurotoxins and risk of cognitive decline and impairment in midlife

    • Carla R. Schubert
    • Mary E. Fischer
    • Karen J. Cruickshanks

    Original Article 17 September 2022 Pages: 149 - 157

15. Optimal MoCA cutoffs for detecting biologically-defined patients with MCI and early dementia

    • Ciro Rosario Ilardi
    • Alina Menichelli
    • Paolo Manganotti

    Original Article Open access 28 September 2022 Pages: 159 - 170

    

16. The microstructural abnormalities of cingulum was related to patients with mild cognitive impairment: a diffusion kurtosis imaging study

    • Yueyang Liu
    • Dongtao Liu
    • Lichun Zhou

    Original Article Open access 28 September 2022 Pages: 171 - 180

    

17. Gait performance and non-motor symptoms burden during dual-task condition in Parkinson’s disease

    • Meimei Zhang
    • Yawen Gan
    • Yumei Zhang

    Original Article 20 September 2022 Pages: 181 - 190

    

18. REM sleep behavior disorder correlates with constipation in de novo Chinese Parkinson’s disease patients

    • Yajing Chen
    • Qian Xu
    • Wei Chen

    Original Article 13 September 2022 Pages: 191 - 197

19. Challenging functional connectivity data: machine learning application on essential tremor recognition

    • Valeria Saccà
    • Fabiana Novellino
    • Aldo Quattrone

    Original Article 20 September 2022 Pages: 199 - 207

    

20. Sleep disorders in Wilson’s disease: a questionnaire study

    • Zhifei You
    • Hui Xu
    • Zhengchen You

    Original Article 15 September 2022 Pages: 209 - 214

    

21. Prevalence and the age of onset patterns of stroke in Jiangsu Province, China

    • Chenlu He
    • Qian Chen
    • Xunbao Zhang

    Original Article 03 October 2022 Pages: 215 - 227

    

22. The PRESTO study: awareness of stroke symptoms and time from onset to intervention

    • Ilaria Gandoglia
    • Erika Schirinzi
    • Massimo Del Sette

    Original Article 03 October 2022 Pages: 229 - 236

    

23. The HALP (hemoglobin, albumin, lymphocyte, and platelet) score is associated with early-onset post-stroke cognitive impairment

    • Minjie Xu
    • Lingli Chen
    • Wenwei Ren

    Original Article 04 October 2022 Pages: 237 - 245

    

24. Non-stenosing carotid artery plaques in embolic stroke of undetermined source: a retrospective analysis

    • Ammar Jumah
    • Hassan Aboul Nour
    • Daniel Miller

    Original Article 27 September 2022 Pages: 247 - 252

    

25. Predictors of 30-day mortality using machine learning approach following carotid endarterectomy

    • Ahmed Mohamed
    • Ashfaq Shuaib
    • Nida Fatima

    Original Article 15 September 2022 Pages: 253 - 261

    

26. Fibrocartilaginous embolism: a rare cause leading to spinal cord infarction?

    • Elisa Francesca Ciceri
    • Valentina Opancina
    • Luisa Chiapparini

    Original Article 17 September 2022 Pages: 263 - 271

    

27. Rapid, non-contact multifocal visual assessment in multiple sclerosis

    • Ted Maddess
    • Joshua P. van Kleef
    • Christian J. Lueck

    Original Article Open access 13 September 2022 Pages: 273 - 279

    

28. Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina

    • Juan I. Rojas
    • Agustín Pappolla
    • Edgar Carnero Contentti

    Original Article 27 September 2022 Pages: 281 - 286

    

29. Power spectrum analysis and outcomes of non-convulsive status epilepticus: a single-center study

    • Jianhua Chen
    • Liri Jin
    • Yan Huang

    Original Article 30 September 2022 Pages: 287 - 295

    

30. Cannabis-based magistral formulation is highly effective as an adjuvant treatment in drug-resistant focal epilepsy in adult patients: an open-label prospective cohort study

    • Cristian Eduardo Navarro

    Original Article 21 September 2022 Pages: 297 - 304

    

31. Functional connectivity alterations in migraineurs with Alice in Wonderland syndrome

    • Claudia Piervincenzi
    • Nikolaos Petsas
    • Patrizia Pantano

    Original Article 17 September 2022 Pages: 305 - 317

    

32. Aseptic meningitis in Fabry disease due to a novel GLA variant: an expanded phenotype?

    • Paulo Ribeiro Nóbrega
    • João Lucas Araújo Morais
    • Fernanda Martins Maia Carvalho

    Original Article 12 September 2022 Pages: 319 - 327

    

33. Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen

    • Laure Le Goff
    • Andreea Seferian
    • Carole Vuillerot

    Original Article 29 September 2022 Pages: 329 - 337

    

34. A true isolated cognitive relapse in multiple sclerosis

    • Valeria Pozzilli
    • Alessandro Cruciani
    • Vincenzo Di Lazzaro

    Brief Communication 08 October 2022 Pages: 339 - 342

    

35. Pediatric tumefactive multiple sclerosis case (with baló-like lesions), diagnostic and treatment challenges

    • Christina Kamari
    • Emmanouil Galanakis
    • Pelagia Vorgia

    Brief Communication Open access 29 September 2022 Pages: 343 - 345

    

36. Stroke-like presentation of autoimmune chorea with positive anti-Yo and anti-MOG antibodies: a case report

    • Manli Ren
    • Qinming Zhou

    Brief Communication 25 October 2022 Pages: 347 - 349

37. Peripheral nerve involvement in wild-type transthyretin amyloidosis

    • Marta Campagnolo
    • Mario Cacciavillani
    • Chiara Briani

    Brief Communication 19 October 2022 Pages: 351 - 354

38. Letter to the Editor: does erythropoietin affect the outcome and complication rates of patient with traumatic brain injury? A pooled analysis

    • Qingyong Zheng
    • Jianguo Xu
    • Xiaofeng Luo

    Letter to the Editor 28 August 2022 Pages: 355 - 356

39. Reversible cerebral venous dilatation syndrome associated to cannabis consumption: Expanding the spectrum of cerebrovascular dysregulation disorders?

    • Simone Rossi
    • Gian Maria Asioli
    • Luca Spinardi

    Letter to the Editor 19 September 2022 Pages: 357 - 359

    

40. Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod

    • Matheus Bernardon Morillos
    • Paulo Henrique Pires de Aguiar
    • Alessandro Finkelsztejn

    Letter to the Editor 29 August 2022 Pages: 361 - 363

    

41. A rare case of meningomyelitis: infective or autoimmune etiology?

    • Sampurna Chowdhury
    • Rajesh Kumar Singh
    • Manjari Tripathi

    Letter to the Editor 21 September 2022 Pages: 365 - 368

    

42. Bilateral hearing loss preceding rhomboencephalitis – a hint for Kelch-like 11 syndrome

    • David Krivitski
    • Yifat Alcalay
    • Avi Gadoth

    Letter to the Editor 16 September 2022 Pages: 369 - 372

    

43. Successful treatment of paroxysmal painful tonic spasms with carbamazepine in a patient with hypertrophic olivary degeneration

    • Alessia Fiore
    • Irene Florindo
    • Elisabetta Chierici

    Letter to the Editor 09 September 2022 Pages: 373 - 375

    

44. Carbamazepine-induced convulsive status epilepticus in benign adult familial myoclonic epilepsy: a case report

    • Tatsuya Ueno
    • Atsuko Katagai
    • Masahiko Tomiyama

    Letter to the Editor 31 August 2022 Pages: 377 - 379

    

45. Rolandic epilepsy with paroxysmal exercise-induced dystonia and writer’s cramp: a case report

    • Sareh Hosseinpour
    • Ali Reza Tavasoli
    • Maziar Emamikhah

    Letter to the Editor 10 September 2022 Pages: 381 - 384

    

46. Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, controlled study Reply to letter to the editor

    • Edoardo Ferlazzo
    • Sara Gasparini
    • Umberto Aguglia

    Letter to the Editor 14 September 2022 Pages: 385 - 387

    

47. Predominant motor neuron involvement as a manifestation of pathogenic (full range) ATXN3 mutations

    • Jarosław Dulski
    • Alexandra Estela Soto Piña
    • Zbigniew K. Wszolek

    Letter to the Editor 23 September 2022 Pages: 389 - 392

    

48. Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial

    • Ali Amini Harandi
    • Hossein Pakdaman
    • Mohammadali Sahraian

    Clinical Trial article 12 September 2022 Pages: 393 - 396

    

49. Anti-Tr/DNER antibody–associated cerebellar ataxia: three rare cases report and literature review

    • Yun Cai
    • Jie Liu
    • Weiying Di

    Clinical Trial article 12 September 2022 Pages: 397 - 403

    

50. Unilateral subcortical extensive dilated perivascular spaces associated with superior sagittal sinus perivenous dilated spaces

    • Dimitri Renard
    • Giovanni Castelnovo
    • Marc Hackius

    Neuro-Images 13 September 2022 Pages: 405 - 407